¼¼°èÀÇ ³²¿ë ¾à¹° °Ë»ç ½ÃÀå
Drugs of Abuse Testing
»óǰÄÚµå : 1760870
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 173 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,106,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,320,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

³²¿ë ¾à¹° °Ë»ç ¼¼°è ½ÃÀåÀº 2030³â±îÁö 62¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 44¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ³²¿ë ¾à¹° °Ë»ç ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 5.8%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 62¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ºÐ¼® Àåºñ´Â CAGR 5.6%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 29¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½Å¼Ó °Ë»ç±â±â ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 4.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 12¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ³²¿ë ¾à¹° °Ë»ç ½ÃÀåÀº 2024³â¿¡ 12¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 14¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 9.1%·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.2%¿Í 4.6%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.8%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ³²¿ë ¾à¹° °Ë»ç ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¾à¹° ³²¿ë °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¾à¹° ³²¿ë »ç·Ê Áõ°¡, Á÷Àå ¹× °ø°ø ¾ÈÀü¿¡ ´ëÇÑ °ü½É Áõ°¡·Î ÀÎÇØ Àü ¼¼°è ¾à¹° °Ë»ç ½ÃÀåÀº ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¾à¹° °Ë»ç´Â ¾à¹° ³²¿ëÀ» ¹ß°ßÇÏ°í ¾ïÁ¦Çϱâ À§ÇØ °í¿ë ½É»ç, ÀÇ·á ȯ°æ, ¹ý ÁýÇà ±â°ü¿¡¼­ Ç¥ÁØ ÀýÂ÷·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. °í¿ëÁÖµéÀº ¾ÈÀüÇÏ°í »ý»êÀûÀÎ ÀÛ¾÷ ȯ°æÀ» º¸ÀåÇϱâ À§ÇØ, ƯÈ÷ ¿î¼Û, °Ç¼³, Á¦Á¶ µî ¾ÈÀüÀÌ Áß¿äÇÑ »ê¾÷¿¡¼­ ¾à¹° °Ë»ç Á¤Ã¥À» µµÀÔÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°è Á¤ºÎ ¹× ±ÔÁ¦ ±â°üÀº ºÒ¹ý ¾à¹° ¿À³²¿ëÀ» ¾ïÁ¦Çϱâ À§ÇØ °ø°øÀå¼Ò, Çб³, ½ºÆ÷Ã÷ À̺¥Æ®¿¡¼­ ¾à¹° °Ë»çÀÇ Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ¾à¹° ³²¿ëÀÌ °øÁß º¸°Ç°ú ¾ÈÀü¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ °Ë»ç ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾à¹° ³²¿ë °Ë»ç¸¦ ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

±â¼ú Çõ½ÅÀº ¾à¹° ³²¿ë °Ë»ç ¼Ö·ç¼ÇÀÇ Á¤È®¼º, È¿À²¼º ¹× Á¢±Ù¼ºÀ» Å©°Ô Çâ»ó½ÃÄ×À¸¸ç, POC(Point-of-Care) °Ë»ç Àåºñ ¹× Áï°¢ÀûÀÎ °Ë»ç ŰƮÀÇ °³¹ß·Î ½Å¼ÓÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â °á°ú¸¦ ¾òÀ» ¼ö ÀÖ°Ô µÇ¾î Á÷Àå °ËÁø ¹× ÀÀ±Þ ÀÇ·á ÇöÀå¿¡¼­ ƯÈ÷ À¯¿ëÇÏ°Ô È°¿ëµÇ°í ÀÖ½À´Ï´Ù. °¡½º Å©·Î¸¶Åä±×·¡ÇÇ-Áú·® ºÐ¼®(GC-MS) ¹× ¾×ü Å©·Î¸¶Åä±×·¡ÇÇ-ÅÄ´ý Áú·® ºÐ¼®(LC-MS/MS)°ú °°Àº °í±Þ Å©·Î¸¶Åä±×·¡ÇÇ ±â¼úÀº ¾à¹° ¹°Áú¿¡ ´ëÇÑ Á¤È®Çϰí Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇϸç, ÀÌ·¯ÇÑ ¹æ¹ýÀº ¹ýÀÇÇÐ ¹× ½ÇÇè½Ç ÇöÀå¿¡¼­ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÇÇè½Ç ½Ã½ºÅÛ¿¡¼­ ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº º¹ÀâÇÑ µ¥ÀÌÅ͸¦ ºÐ¼®Çϰí ÇØ¼®ÇÏ´Â ´É·ÂÀ» °­È­ÇÏ¿© ÀÎÀû ¿À·ù¸¦ ÁÙÀÔ´Ï´Ù. ¶ÇÇÑ Å¸¾× ±â¹Ý °Ë»ç ÀåÄ¡³ª ¿þ¾î·¯ºí °Ë»ç ÀåÄ¡¿Í °°Àº Çõ½ÅÀûÀÎ Á¦Ç°µµ µîÀåÇÏ¿© °Ë»ç ¼Ö·ç¼ÇÀÇ Àû¿ë ¹üÀ§¸¦ ³ÐÈ÷´Â ºñħ½ÀÀûÀ̰í Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ ¿É¼ÇÀÌ Á¦°øµÇ°í ÀÖ½À´Ï´Ù.

¾à¹° ³²¿ë °Ë»ç ½Ã½ºÅÛÀº ¾îµð¿¡¼­ °¡Àå ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï±î?

¾à¹° ³²¿ë °Ë»ç ½Ã½ºÅÛÀº Á÷Àå, ¹ý ÁýÇà ±â°ü, ÀÇ·á ½Ã¼³, ±³À° ±â°ü µî ´Ù¾çÇÑ »ê¾÷ ¹× ºÐ¾ß¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ±â¾÷¿¡¼­´Â ƯÈ÷ ¾ÈÀüÀÌ ÃÖ¿ì¼±½ÃµÇ´Â »ê¾÷¿¡¼­ Á÷¿øµéÀÌ È¸»ç Á¤Ã¥À» ÁؼöÇϰí ÀÖ´ÂÁö È®ÀÎÇϱâ À§ÇØ Å×½ºÆ® ÇÁ·Î±×·¥À» ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. ¹ý ÁýÇà ±â°üÀº ÀÌ·¯ÇÑ ½Ã½ºÅÛÀ» »ç¿ëÇÏ¿© À½ÁÖ ¿îÀüÀÚ¸¦ ½Äº°ÇÏ°í µµ·Î¿¡¼­ Á¦°ÅÇϱâ À§ÇØ µµ·Î °Ë»ç¸¦ ½Ç½ÃÇÕ´Ï´Ù. ÀÇ·á ½Ã¼³°ú ÀçȰ¼¾ÅÍ¿¡¼­´Â Áßµ¶À¸·Î °íÅë¹Þ´Â ȯÀÚÀÇ Áø´Ü ¹× Ä¡·á ¸ð´ÏÅ͸µÀÇ ÀÏȯÀ¸·Î ¾à¹° °Ë»ç¸¦ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±³À° ±â°ü, ƯÈ÷ ¹Ì±¹¿¡¼­´Â ¾à¹° ³²¿ëÀ» ¹æÁöÇϱâ À§ÇØ ÇлýÀ» ´ë»óÀ¸·Î ¹«ÀÛÀ§ ¾à¹° °Ë»ç¸¦ ½Ç½ÃÇß½À´Ï´Ù. ÀÌó·³ ´Ù¾çÇÑ È¯°æ¿¡¼­ ¾à¹° °Ë»ç ¼Ö·ç¼ÇÀÌ ±¤¹üÀ§ÇÏ°Ô È°¿ëµÇ°í ÀÖ´Â °ÍÀº ¾ÈÀü°ú ÄÄÇöóÀ̾𽺠À¯Áö¿¡ ÀÖ¾î ¾à¹° °Ë»ç ¼Ö·ç¼ÇÀÌ ¾ó¸¶³ª Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´ÂÁö¸¦ Àß º¸¿©ÁÝ´Ï´Ù.

¾à¹° ³²¿ë °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¾à¹° ³²¿ë °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀº ¾à¹° ³²¿ë »ç·Ê Áõ°¡, ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø °­È­, °Ë»ç ±â¼úÀÇ ¹ßÀü µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¾à¹° »ç¿ë, ƯÈ÷ ¿ÀÇÇ¿ÀÀ̵å¿Í ÇÕ¼º ¾à¹°ÀÇ È®»êÀ¸·Î ÀÎÇØ Á¤ºÎ¿Í °í¿ëÁÖ ¸ðµÎ Á¶±â ¹ß°ß ¹× °³ÀÔÀ» À§ÇÑ ¼±º° ÇÁ·Î±×·¥À» ¿ì¼±¼øÀ§·Î »ï°í ÀÖ½À´Ï´Ù. °íÀ§Çè »ê¾÷ ¹× °ø°ø ºÎ¹®ÀÇ ¾à¹° °Ë»ç¸¦ Àǹ«È­ÇÏ´Â ±ÔÁ¦ Á¤Ã¥Àº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Áï°¢ÀûÀÎ POC ±â±â ¹× °í±Þ °Ë»ç ½Ã½ºÅÛ µî °Ë»çÀÇ Á¤È®¼º°ú ÆíÀǼºÀ» Çâ»ó½ÃŰ´Â ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº Á¡Á¡ ´õ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾î ´Ù¾çÇÑ »ê¾÷ ºÐ¾ß¿¡¼­ ¸Å·ÂÀûÀ¸·Î ´Ù°¡¿À°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °Ë»ç ½Ã½ºÅÛ¿¡ AI¿Í ÀÚµ¿È­¸¦ ÅëÇÕÇÏ¿© È¿À²¼º°ú µ¥ÀÌÅÍ Á¤È®¼ºÀ» ÃÖÀûÈ­ÇÔÀ¸·Î½á ÇコÄɾî, ¹ý ÁýÇà ±â°ü ¹× ±â¾÷ ºÎ¹®¿¡¼­ äÅ÷üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(¼Òº¯, Ÿ¾×, ¸ð¹ß, ±âŸ »ùÇà À¯Çü), ÃÖÁ¾»ç¿ëÀÚ(¹ýÀÇÇÐ ¿¬±¸¼Ò, ¹ýÁýÇà±â°ü, Áø´Ü ½ÇÇè½Ç, º´¿ø, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 41°³»ç)

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Drugs of Abuse Testing Market to Reach US$6.2 Billion by 2030

The global market for Drugs of Abuse Testing estimated at US$4.4 Billion in the year 2024, is expected to reach US$6.2 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Analyzers, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.9 Billion by the end of the analysis period. Growth in the Rapid Testing Devices segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 9.1% CAGR

The Drugs of Abuse Testing market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Drugs of Abuse Testing Market - Key Trends & Drivers Summarized

Why Is There a Surge in the Demand for Drugs of Abuse Testing?

The global drugs of abuse testing market is expanding rapidly due to increasing substance abuse cases and the rising focus on workplace and public safety. Drug testing is becoming a standard procedure in employment screenings, healthcare settings, and law enforcement agencies to detect and deter substance abuse. Employers are increasingly implementing drug testing policies to ensure a safe and productive work environment, particularly in safety-sensitive industries like transportation, construction, and manufacturing. Furthermore, governments and regulatory bodies worldwide are emphasizing the importance of drug testing in public spaces, schools, and sports events to curb the misuse of illicit substances. The rising awareness about the impact of drug abuse on public health and safety continues to drive the adoption of testing solutions across multiple sectors.

How Are Technological Advancements Transforming Drugs of Abuse Testing?

Technological innovations have significantly improved the accuracy, efficiency, and accessibility of drugs of abuse testing solutions. The development of point-of-care (POC) testing devices and instant testing kits allows for quick and reliable results, which are particularly useful in workplace screenings and emergency medical settings. Advanced chromatography techniques, such as gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS), provide highly accurate and comprehensive analysis of drug substances, making these methods preferred in forensic and laboratory settings. Additionally, the integration of artificial intelligence (AI) and machine learning in lab systems enhances the ability to analyze and interpret complex data, reducing human error. Innovations like saliva-based and wearable testing devices are also emerging, providing non-invasive and continuous monitoring options that expand the applicability of testing solutions.

Where Are Drugs of Abuse Testing Systems Most Commonly Applied?

Drugs of abuse testing systems are widely used across various industries and sectors, including workplaces, law enforcement, healthcare facilities, and educational institutions. In the corporate sector, testing programs are implemented to ensure employee compliance with company policies, especially in industries where safety is paramount. Law enforcement agencies use these systems to conduct roadside tests, ensuring that drivers under the influence are identified and kept off the roads. Healthcare facilities and rehabilitation centers utilize drug testing as part of diagnosis and treatment monitoring for patients struggling with addiction. Additionally, educational institutions, particularly in the United States, conduct random drug tests among students to prevent substance abuse. The broad application of drug testing solutions across these diverse settings highlights their importance in maintaining safety and compliance.

What Factors Are Driving the Growth of the Drugs of Abuse Testing Market?

The growth in the drugs of abuse testing market is driven by several factors, including rising incidences of substance abuse, increased regulatory support, and advancements in testing technologies. The prevalence of drug use, particularly opioids and synthetic drugs, has prompted both governments and employers to prioritize screening programs for early detection and intervention. Regulatory policies mandating drug testing in high-risk industries and public sectors further propel market growth. Technological advancements that enhance the accuracy and convenience of testing-such as instant POC devices and sophisticated laboratory systems-make these solutions increasingly accessible and attractive to various industries. Additionally, the integration of AI and automation in testing systems optimizes efficiency and data accuracy, boosting adoption rates across healthcare, law enforcement, and corporate sectors.

SCOPE OF STUDY:

The report analyzes the Drugs of Abuse Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Analyzers, Rapid Testing Devices, Consumables); Sample Type (Urine, Saliva, Hair, Other Sample Types); End-Use (Forensic Laboratories, Law Enforcement Agencies, Diagnostic Laboratories, Hospitals, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â